This topic contains a solution. Click here to go to the answer

Author Question: Which of the following did NOT occur after Charlemagne's death? A) The Umayyad Caliphate ... (Read 193 times)

silviawilliams41

  • Hero Member
  • *****
  • Posts: 560
Which of the following did NOT occur after Charlemagne's death?
 
  A) The Umayyad Caliphate conquered the Frankish kingdom.
  B) Emperor Frederick Barbarossa canonized Charlemagne.
  C) The Frankish kingdom fractured, leading to a period of violence and hardship.
  D) His bones were placed inside works of art, as a way of paying tribute.

Question 2

Neumes are a type of notation used in which context?
 
  A) psalters
  B) illuminated manuscripts
  C) musical notation of Gregorian chant
  D) the Vulgate Bible



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lindahyatt42

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

A

Answer to Question 2

C





 

Did you know?

For about 100 years, scientists thought that peptic ulcers were caused by stress, spicy food, and alcohol. Later, researchers added stomach acid to the list of causes and began treating ulcers with antacids. Now it is known that peptic ulcers are predominantly caused by Helicobacter pylori, a spiral-shaped bacterium that normally exist in the stomach.

Did you know?

Giardia is one of the most common intestinal parasites worldwide, and infects up to 20% of the world population, mostly in poorer countries with inadequate sanitation. Infections are most common in children, though chronic Giardia is more common in adults.

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library